Evidence map›Paper›PMID 37795074›Full record

ArticleCureus2023

Gitelman Syndrome and Hypertension: A Case Report.

Hiba Shaukat, Shazaan Nadeem, Fnu Abdullah, Muhammad Muntazir Mehdi Khan, Syed W Rizvi

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. A novel variant ofAME case reports · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Hiba ShaukatMedicine, Allama Iqbal Medical College, Lahore, PAK.
Shazaan NadeemInternal Medicine, Medical University Sofia, Sofia, BGR.
Fnu AbdullahInternal Medicine, Jinnah Sindh Medical University, Karachi, PAK.
Muhammad Muntazir Mehdi KhanSurgery, Ohio State University Wexner Medical Center, Columbus, USA.
Syed W RizviMedicine, University of Medicine and Dentistry of New Jersey, Newark, USA.
The Ohio State University Wexner Medical Center · USJinnah Sindh Medical University · PKMedical University of Sofia · BGUniversity Hospital, Newark · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a patient with persistent hypokalemia, it is important to consider Gitelman syndrome, a rare, salt-wasting tubulopathy inherited in an autosomal recessive pattern. Gitelman syndrome leads to electrolyte abnormalities like hypokalemia, hypomagnesemia, and metabolic alkalosis. Typical clinical features include muscle cramps, fatigue, polydipsia, and salt cravings. Our case involves a female patient in her early 40s who visited the endocrinology clinic with symptoms of polyuria, constipation, muscle weakness, and fatigue. Electrolyte abnormalities included hypokalemia, hypomagnesemia, hypochloremia, and hyperreninemia. Initial tests, such as renal function tests, renal ultrasound, and CT scan, yielded normal results. Differential diagnosis of Gitelman syndrome and Bartter syndrome was considered due to the mutual electrolyte abnormalities of hypokalemia and metabolic alkalosis. Bartter syndrome was ruled out in our patient due to the presence of hypomagnesemia, which indicates a different defective receptor. Ultimately, genetic testing would be necessary to confirm the diagnosis of Gitelman syndrome considering the characteristic electrolyte disturbances and classic clinical presentation of fatigue, weakness, and salt craving.

Indexed as

gitelman syndromehyperreninemiahypochloremiahypomagnesemiapersistent hypokalemiasalt-losing tubulopathy

Identifiers

PMID37795074
PMCPMC10545885
OpenAlexW4386401258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.